LEADER 03261nam  22010093a 450 
001 9910367751903321
005 20250203235437.0
010   $a9783039216772
010   $a3039216775
024 8 $a10.3390/books978-3-03921-677-2
035   $a(CKB)4100000010106198
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/54599
035   $a(ScCtBLL)11dc1b6a-e5e4-457d-b656-26a0e89e0cfb
035   $a(OCoLC)1163804709
035   $a(EXLCZ)994100000010106198
100   $a20250203i20192019  uu 
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aNew Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases : $eLessons From The Past and Future Challenges /$fAhmed Bakillah
210  1$aBasel, Switzerland :$cMDPI,$d2019.
215   $a1 electronic resource (116 p.)
311 08$a9783039216765 
311 08$a3039216767 
330   $aThis book illustrates some of the most recent research efforts that have been made in lowering plasma cholesterol levels in patients with CVD. Selected articles aimed to illuminate advances and urgent challenges in the management of CVD, including disease management using statin-combined therapeutic strategies.
610   $aapolipoprotein
610   $alipids
610   $arisk stratification
610   $aproprotein convertase subtilisin-kexin type 9 (PCSK9)
610   $avaspin
610   $asphingolipids
610   $aPCSK9
610   $aceramides
610   $aatrial fibrillation
610   $acircular RNA
610   $aSTEMI
610   $acholesterol
610   $alipoproteins
610   $acardiovascular disease (CVD)
610   $acoronary artery bypass grafting
610   $aatherosclerosis
610   $astatin
610   $aLDL subfractions
610   $aacute kidney injury
610   $adyslipidemia
610   $agene expression
610   $aNSTEMI
610   $aNAFLD
610   $ahyperlipidemia
610   $anonstatin
610   $acholesteryl ester transfer protein
610   $alow-density lipoprotein cholesterol
610   $aanacetrapib
610   $aHDL
610   $aacute coronary syndrome
610   $amiRNA
610   $acardiovascular risk
610   $apleiotropic actions
610   $agenetic
610   $aABCA1
610   $asdLDL
610   $acardiovascular disease
610   $aproprotein convertase subtilisin/kexin type 9
610   $ainclisiran
610   $areverse cholesterol transport
610   $asterol
610   $asmall interfering RNA (siRNA)
610   $aRNA-binding proteins
610   $acardiovascular diseases
610   $aNASH
610   $alow-density lipoprotein-cholesterol (LDL-C)
610   $astroke
610   $anutrigenetics
610   $atype 2 diabetes
610   $astatins
610   $asphingomyelin
610   $ahepatic fibrosis
610   $adiabetes
700   $aBakillah$b Ahmed$01287692
801  0$bScCtBLL
801  1$bScCtBLL
906   $aBOOK
912   $a9910367751903321
996   $aNew Lipid Lowering Therapies For Cardiovascular and Metabolic Diseases$94322787
997   $aUNINA